title: [Dynamics of tumour necrosis factor-alpha and clinical signs of osteoarthrosis during the treatment with alflutop in combination with peloid applications under conditions of health resort].
abstract: The objective of the present work was to develop indications for the combined treatment of patients presenting with osteoarthrosis including the use of peloid applications and intramuscular injections of alflutop. The study was based at Yakty-Kul' health resort and included 94 patients at the age from 40 to 59 years. The proposed method was shown to have beneficial effect on the patients' clinical conditions. In addition, the treatment caused a decrease in the level of tumour necrosis factor-alpha (TNF-alpha) that turned out to be related to the articular index.
authors.forename: V A
authors.initials: VA
authors.lastname: Maganev
authors.forename: R A
authors.initials: RA
authors.lastname: Davletshin
authors.forename: G K
authors.initials: GK
authors.lastname: Davletshina
authors.forename: G S
authors.initials: GS
authors.lastname: Iapparov
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D001486:Bashkiria; D003131:Combined Modality Therapy; D006294:Health Resorts; D006801:Humans; D007273:Injections, Intramuscular; D007596:Joints / Q000503:physiopathology; D008875:Middle Aged; D009094:Mud Therapy / Q000379:methods*; D010003:Osteoarthritis / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000628:therapy*; D011859:Radiography; D020127:Recovery of Function; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000097:blood*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D014409:Tumor Necrosis Factor-alpha